Recurrent Nephropathy among Immunocompromised Persons could Warrant BK Polyomavirus Testing
DOI:
https://doi.org/10.60787/njgp.v16i2.99Abstract
Dear Editor,
BK virus (BKV) is a naked DNA virus, which belongs to the Polyomaviridae family. BK and JC polyomaviruses were the first human polyomaviruses isolated from immunosuppressed patients.[1,2] BKV was first isolated in 1971 from the urine of an immunocompromised renal transplant patient with the initials B.K.[2] BKV causes interstitial nephritis in kidney transplant patients but has also been reported to cause renal diseases in nonrenal transplant patients and bone marrow transplant recipients.[3] The BKV seroprevalence stood as high as 81%, with the virus in latent/dormant stage embedded in the urothelium.[4] Intermittent reactivation with low-level viruria (106 virus copies/mL of urine) has been noted in approximately 5% of immunocompromised patients without clinical consequence.[5] Due to the detection of viral DNA in tonsillar tissue, BKV transmission is thought to occur via a respiratory route.[6] There is also evidence for other possible routes of transmission such as fecal-oral, urino-oral, transplacental, and blood transfusion.[6] There are four BKV genotypes: designated I, II, III, and IV. After primary infection, BKV enters a latency phase and tends to persist indefinitely.[7] Autopsy studies have detected BKV mainly in kidney parenchyma, renal pelvis, ureter, and urinary bladder of immunocompetent individuals.[7] Reactivation of BKV replication is observed in states of relative or absolute immunodeficiency such as transplantation, pregnancy, diabetes, cancer, HIV infection, and systemic lupus erythematosus. Unchecked BKV replication can then lead to BKV nephropathy (BKVN) and other organ diseases.
Download the PDf file for more.
Downloads
References
Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation.
Lancet 1971;1:1253‑7.
Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971;1:1257‑60.
Kuppachi S, Kaur D, Holanda DG, Thomas CP. BK polyoma virus infection and renal disease in non-renal solid organ transplantation. Clin
Kidney J 2016;9:310‑8.
Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, et al. Population-based study of antibody to the human polyomaviruses
BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003;71:115‑23.
Randhawa P, Uhrmacher J, Pasculle W, Vats A, Shapiro R, Eghtsead B, et al. A comparative study of BK and JC virus infections in organ
transplant recipients. J Med Virol 2005;77:238‑43.
Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of polyomaviruses in human disease. Virology 2009;384:266‑73.
Sharma PM, Gupta G, Vats A, Shapiro R, Randhawa P. Phylogenetic analysis of polyomavirus BK sequences. J Virol 2006;80:8869‑79.
Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002;347:488‑96.
Vats A, Shapiro R, Singh Randhawa P, Scantlebury V, Tuzuner A, Saxena M, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003;75:105‑12.
Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005;5:582‑94.
Nickeleit V, Hirsch HH, Binet IF, Gudat F, Prince O, Dalquen P, et al. Polyomavirus infection of renal allograft recipients: From latent
infection to manifest disease. J Am Soc Nephrol 1999;10:1080‑9.
Published
Issue
Section
License
Copyright (c) 2024 Nigerian Journal of General Practice

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.